(Q44188892)

30 November 2017

title

Capped dipeptide alpha-ketoacid inhibitors of the HCV NS3 protease (English)

1 reference

30 November 2017

Emanuela Nizi

1

1 reference

30 November 2017

Uwe Koch

2

1 reference

30 November 2017

Simona Ponzi

3

1 reference

30 November 2017

Victor G Matassa

4

1 reference

30 November 2017

Cristina Gardelli

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

number of pages

4

1 reference

Bioorganic & Medicinal Chemistry Letters

inferred from page(s)

published in

1 reference

30 November 2017

volume

12

1 reference

30 November 2017

issue

22

1 reference

30 November 2017

page(s)

3325-3328

1 reference

The scientific challenge of hepatitis C.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Evolution, synthesis and SAR of tripeptide alpha-ketoacid inhibitors of the hepatitis C virus NS3/NS4A serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

A designed P1 cysteine mimetic for covalent and non-covalent inhibitors of HCV NS3 protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Alpha-ketoacids are potent slow binding inhibitors of the hepatitis C virus NS3 protease

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Inhibition of the hepatitis C virus NS3/4A protease. The crystal structures of two protease-inhibitor complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Substrate specificity of the hepatitis C virus serine protease NS3.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

Role of charged residues in the catalytic mechanism of hepatitis C virus NS3 protease: electrostatic precollision guidance and transition-state stabilization

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900691-1

7 January 2021

10.1016/S0960-894X(02)00691-1

Identifiers

DOI

1 reference

30 November 2017

1 reference